Chapter 9 offers a comprehensive examination of the life sciences sector, presenting benchmarks for procurement staffing and spending that reflect the industry’s unique characteristics. The sector includes a diverse array of organizations, such as biotechnology firms, pharmaceutical companies, medical device companies, and research institutions. The 34 survey respondents vary in size, with organizations reporting annual revenues ranging from approximately $400 million to over $50 billion, highlighting the sector’s broad economic impact.
Procurement Budgets, Staffing, and Process Metrics 2025/2026: Chapter 9: Life Sciences Sector Benchmarks
November, 2025
DISCLAIMER:
Avasant's research and other publications are based on information from the best available sources and Avasant's independent assessment and analysis at the time of publication. Avasant takes no responsibility and assumes no liability for any error/omission or the accuracy of information contained in its research publications. Avasant does not endorse any provider, product or service described in its RadarView™ publications or any other research publications that it makes available to its users, and does not advise users to select only those providers recognized in these publications. Avasant disclaims all warranties, expressed or implied, including any warranties of merchantability or fitness for a particular purpose. None of the graphics, descriptions, research, excerpts, samples or any other content provided in the report(s) or any of its research publications may be reprinted, reproduced, redistributed or used for any external commercial purpose without prior permission from Avasant, LLC. All rights are reserved by Avasant, LLC.